All of the ratings and research analysts listed below are considered good indicators when analyzing whether a stock has growth potential for the quarter.
If one of the research analysts gives a stock a good rating, indicating a price target that is considerably above the stock's market value, then we can consider the stock to have high growth potential for the quarter.
Only stocks that are recommended by one or more of the research analysts listed below and that have a specific buy recommendation (“Buy”, “Strong Buy”) or that are expected to perform slightly better than the market return (“Outperform”, Overweight, “Above Average”) will be considered eligible for trading.
RATINGS |
---|
Buy |
Strong Buy |
Outperform |
Overweight |
Above Average |
RESEARCH ANALYSTS |
---|
Argus |
Auriga |
Barclays |
BMO Capital Markets |
BofA/Merrill |
Brean Murray |
Broadpoint AmTech |
Canaccord Genuity |
Cantor Fitzgerald |
CIBC Wrld Mkts |
Citigroup |
Collins Stewart |
Deutsche Bank |
FBR Capital |
Jefferies |
JMP Securities |
JP Morgan |
KeyBanc Capital Mkts |
Lazard Capital Mkts |
Longbow |
Merrill Lynch |
Merriman |
Morgan Joseph |
Morgan Keegan |
Morgan Stanley |
Needham |
Northland Securities |
Oppenheimer |
Piper Jaffray |
RBC Capital Mkts |
Robert W. Baird |
Rodman & Renshaw |
Roth Capital |
Sterne Agee |
Stifel |
Sun Trust Rbsn Humphrey |
The Benchmark Company |
ThinkEquity |
Thomas Weisel |
UBS |
Wedbush |
Wells Fargo |
William Blair |
Wunderlich |